Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
Sports
History
News
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts221/v4/f2/62/4d/f2624de8-a599-673d-cf8d-b7d3489dc39d/mza_6493005519951327936.jpg/600x600bb.jpg
Melanoma Matters
Melanoma Matters Pod
75 episodes
6 days ago
From the UK to the USA - Melanoma Matters is on a mission! Hosts James Larkin and Sapna Patel are spreading the word on melanoma, one podcast at a time. Tune in for a critical review of the literature and a discussion of how we incorporate the data into our practices...across the pond(s). #MelanomaMatters video podcast
Show more...
Medicine
Health & Fitness
RSS
All content for Melanoma Matters is the property of Melanoma Matters Pod and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
From the UK to the USA - Melanoma Matters is on a mission! Hosts James Larkin and Sapna Patel are spreading the word on melanoma, one podcast at a time. Tune in for a critical review of the literature and a discussion of how we incorporate the data into our practices...across the pond(s). #MelanomaMatters video podcast
Show more...
Medicine
Health & Fitness
https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_episode/41860148/41860148-1742858104794-615762d6bc7d5.jpg
Ep 64: Guest Clare Turnbull Part 2
Melanoma Matters
46 minutes 11 seconds
7 months ago
Ep 64: Guest Clare Turnbull Part 2

In this episode of Melanoma Matters, hosts James Larkin and Sapna Patel pick up with Part 2 of 2 - a deep conversation with Claire Turnbull - about the complexities of cancer screening, overdiagnosis, and the role of genetic testing. They explore the implications of screening practices illustrated by the Gilbert Welch paradigm, the challenges faced in patient management, and the future of genetic testing in oncology. The discussion emphasizes the importance of understanding the risks and benefits associated with genetic testing.

Keywords

melanoma, cancer screening, overdiagnosis, genetic testing, patient management, healthcare, public health, cancer research, screening guidelines, cancer predisposition


Takeaways

• The conversation highlights the importance of understanding the value of cancer screening.

• Overdiagnosis is a significant concern in cancer screening practices.

• Genetic testing plays a crucial role in identifying cancer predisposition.

• Screening should be evaluated rigorously to ensure it benefits patients.

• The implications of false positives in screening can lead to unnecessary anxiety for patients.

• Healthcare providers must be responsible for interpreting test results they order.

• The need for genetic counseling is critical in managing test results and patient care.

• There is a growing concern about the overuse of broad genetic testing panels.

• Future advancements in technology may improve screening methods.

• Public health messaging must address the complexities of cancer screening and genetic testing.


Chapters

00:00 Clare Turnbull - Part 2 of 2

04:05 High penetrance, common SNPs, and in betweens

07:15 The Gilbert Welch Paradigm

12:30 Understanding Lead Time and Overdiagnosis

16:11 Randomized Trials in Screening

19:59 Consequences of Screening: Overdiagnosis and Anxiety

22:22 Debate on Screening Protocols and Their Efficacy

25:37 Need for Evidence-Based Genetic Testing

31:19 Ripple Effects of Genetic Testing on Families

34:00 Fact Check

35:47 Genetic testing for ACC?!

36:34 Clinical Genetics clinics are NOT just reading guidelines...

39:52 David Sackett: Evidence-Based Medicine

43:03 Triggering James: (S)he who orders the test reviews & interprets the test



Melanoma Matters
From the UK to the USA - Melanoma Matters is on a mission! Hosts James Larkin and Sapna Patel are spreading the word on melanoma, one podcast at a time. Tune in for a critical review of the literature and a discussion of how we incorporate the data into our practices...across the pond(s). #MelanomaMatters video podcast